Search results
Author(s):
Hasan Jilaihawi
,
João L Cavalcante
,
Nicolas M Van Mieghem
,
et al
Added:
1 year ago
Medical Imaging within the cardiovascular arena is constantly subject to changes and new innovations. Pie Medical Imaging (PMI) is a software company that strives to be a front runner in this field.
This page gives an overview of PMI’s latest software developments.
Find out more about Pie Medical Imaging
View more
Author(s):
Claudia Agabiti-Rosei
,
Anna Paini
,
Massimo Salvetti
Added:
3 years ago
Uric acid (UA) represents the final product of purine metabolism, in humans mainly regulated by the xanthine-oxidoreductase enzyme, which converts hyoxantine to xanthine and xanthine to UA. Dietary factors may influence serum UA (SUA), increasing its levels (meat, seafood, fructose, alcohol and sodium) or decreasing them (coffee and ascorbic acid). In addition, high cellular turnover conditions,…
View more
Author(s):
Eric Larose
,
Olivier F Bertrand
Added:
3 years ago
Cardiovascular magnetic resonance (CMR) has found widespread use as an important tool in the cardiologists' armamentarium for several years now, mainly because of superior diagnostic accuracy and ability to perform complete anatomical and functional assessment in a single study without ionising radiation. The following will summarise specific uses of CMR for the interventional cardiologist.
…
View more
Author(s):
Adrian JB Brady
Added:
3 years ago
Hypertension is the single most important preventable cause of premature death in the Western world. The quest to find the most effective treatment both in terms of blood pressure control and prevention of events, such as heart attacks and strokes, is on-going. The issue of which antihypertensive agent to use first-line has been the subject of debate for over two decades. The lack of a coherent…
View more
Author(s):
David Playford
,
Kate Hanneman
Added:
1 month ago
In this video, Dr Kate Hanneman (University of Toronto, CA) and Prof David Playford (Hollywood Private Hospital, AU) sit down to discuss the main talking points raised by the recent AHA scientific statement, "Value Creation Through Artificial Intelligence and Cardiovascular Imaging".Recorded remotely from Toronto and Nedlands, 2024.Editor: Jordan RanceVideo Specialist: Dan Brent
View more
Ep 6: Inflammatory Biomarkers and Cardiovascular Risk
Author(s):
Bruna Gigante
Added:
1 year ago
Podcast Episode
Nocturnal Hypertension
Author(s):
Roland Asmar
,
,
,
et al
Start date:
Feb 08, 2022
Broadcast
Author(s):
Adrian JB Brady
Added:
3 years ago
Hypertension is the single most important preventable cause of premature death in the Western world. The quest to find the most effective treatment both in terms of blood pressure control and prevention of events, such as heart attacks and strokes, is on-going. The issue of which antihypertensive agent to use first-line has been the subject of debate for over two decades. The lack of a coherent…
View more
Author(s):
Bruna Gigante
Added:
1 year ago
What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event?
Join Dr Bruna Gigante (Karolinska Institute, Solna, SE) in a discussion of potential biomarkers which may impact a patient’s cardiovascular risk profile. In this month’s featured author episode of the ECR Podcast, Dr Gigante discusses novel biomarkers and the clinical challenges which may be…
View more
Author(s):
Yukiko Isekame
,
Sabiha Gati
,
Jose Antonio Aragon-Martin
,
et al
Added:
3 years ago
Marfan syndrome (MFS) is a disease in which connective tissue becomes weak secondary to fibrillin-1 mutations, resulting in aortic dilatation, aneurysm formation, aortic dissection, aortic regurgitation and mitral valve prolapse (MVP; see Table 1).
Epidemiology
MFS is an autosomal dominant condition: 75 % of all patients inherit the condition from one affected parent and 25 % are affected as…
View more